Navigation Links
Everest Data on Short- and Long-Term Use of Otsuka's,Investigational Novel Treatment, Tolvaptan, Published in Journal of,the American Medical Association and Featured in ACC's Late,Breaking Clinical Trials

al., "Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial." JAMA 2007;297:1319- 1331.

Gheorghiade, M, et al., "Short-Term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure: The EVEREST Clinical Status Trials." JAMA 2007;297:1332-1343.

ACC Presentation: 402-7

Session: ACC.07 Late-Breaking Clinical Trials I, Sunday, Mar 25, 2007, 8:30 AM -10:00 AM CST. Presentation Start Time: Sunday, Mar 25, 2007, 8:50 AM CST Effects of Vasopressin Receptor Antagonism With Tolvaptan on Clinical Status, Morbidity and Mortality in Patients Hospitalized With Acute Decompensated Heart Failure: Results of the EVEREST Trial Marvin A. Konstam, Mihai Gheorghiade, John C. Burnett, Jr., Liliana Grinfeld, Aldo P. Maggioni, Karl Swedberg, Faiez Zannad, James E. Udelson, Christopher A. Zimmer, Cesare Orlandi for the EVEREST Investigators.

    (1) Gheorghiade M, Konstam MA, Burnett JC, et al. Short-Term Clinical

        Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients

        Hospitalized for Heart Failure:  The EVEREST Clinical Status Trials.

        JAMA. 2007;297:1332-1343.


    (2) Konstam MA, Burnett JC, Gheorghiade M, et al. Effects of Oral

        Tolvaptan in Patients Hospitalized for Worsening Heart Failure:  The

        EVEREST Outcome Trial. JAMA. 2007;297:1319-1331.


    (3) Rosamond W, Flegal K, Friday G, et al; Heart Disease and Stroke

        Statistics - 2007 Update A Report From the American Heart Association

        Statistics Committee and Stroke Statistics Subcommittee. Circulation.

        2007;115:e69-e171.


    (4) Press Release.  "FDA Approves Astellas' VAPRISOL(R) For The Treatment

        Of Euvolemic Hyponatremia."  Astellas, December 30, 2005.


    (5) Verbalis JG. AVP Receptor Antagonists as Aquaretics: Review and

        Assessment of Clinical Data. Cleveland Clinic J Med 2006;73(3):S24-33.


    (6
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
2. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
3. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
4. Anesiva Announces Phase 2 Data Showing Substantial, Long-Term Pain Reductions with Adlea(TM) (formerly 4975) in Osteoarthritis of the Knee
5. Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival
6. Surfaxin (Lucinactant) Long-Term Survival Advantage vs. Comparators Published in Pediatrics
7. Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up
8. New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia
9. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
10. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
11. UCB Presents Long-Term CImzia Data in Crohns Disease
Post Your Comments:
(Date:1/23/2015)... Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & ... for shareholders detailing why a "YES" vote to increase the ... As we reflect upon the 2014 fiscal year ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ ... its CytoSorb® extracorporeal cytokine adsorber to reduce deadly ... the receipt of $385,642, net of transaction costs, ... the Technology Business Tax Certificate Transfer Program sponsored ...
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced ... have been enrolled into the Company,s Phase 2 clinical ... safety of Gem,s lead compound, GPX-150 (an investigational medication), ... or metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased to announce ... Services at North Carolina State’s College of Veterinary Medicine ... Award for Distinguished Volunteer Service—the organization’s highest award. ... of volunteer experts to direct its work to improve ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the release of ... kids with cancer. The Chemo Duck App, available on iTunes for ... games to help children of all ages living with cancer adjust ... kids entertained, educated and at ease while waiting for clinic visits ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue ... means to “Live Fearless.” , The “Faces of ... stories about how they or someone they know has faced ... in the moment. By telling these types of stories through ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... Mean Unbeatable Consumer Value Queen c2 Mattress Starts at $699.99; One ... ... Minneapolis, MN (Vocus) February 26, 2009 -- In today,s uncertain economy, ... while they are buying fewer things, they are buying when they ...
... Dean Farms in New Castle, Lawrence County, has ... sales of raw milk on Feb. 26, Pennsylvania Agriculture ... that has not been pasteurized. Pennsylvania farms selling raw ... milk laboratory tested due to the health risks associated ...
... 26 The Communications Workers of America commended President ... administration,s proposed budget that will move our nation closer ... budget plan, the President has signaled his commitment to ... quality, affordable care. He understands the economic toll that ...
... hospitals tracked by HIMSS Analytics has achieved this recognition for implementation of ... ... As the country moves to transform healthcare with the passing of the ... 6 by HIMSS Analytics serve as role models in healthcare IT ...
... The Susan G. Komen for the Cure(R) Advocacy ... groundwork for fundamental health care reform and for ... to cancer with the release of his first ... Tuesday evening to hear President Obama voice his ...
... Predictive medicine company PreMD Inc. (TSX: PMD; PREMF.pk) today ... of the Corporation. Mr. Davis has been a director ... express my sincere thanks to Paul for his contribution ... PreMD.About PreMD Inc.PreMD Inc. has rapid, non-invasive tests for ...
Cached Medicine News:Health News:Select Comfort Launches Entirely Redesigned Line Of Sleep Number Beds 2Health News:Select Comfort Launches Entirely Redesigned Line Of Sleep Number Beds 3Health News:Select Comfort Launches Entirely Redesigned Line Of Sleep Number Beds 4Health News:Lawrence County Raw Milk Dairy Tests Negative For Campylobacter; Raw Milk Sales Resumed 2Health News:Honored for EMR Sophistication, HIMSS Analytics Announces Stage 6 Hospitals 2Health News:Honored for EMR Sophistication, HIMSS Analytics Announces Stage 6 Hospitals 3Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Obama for Commitment to Health Reform, Cancer Research, in Budget Blueprint 2Health News:PreMD Announces Resignation of Director 2
... CVS4 Complete Vascular System combines cutting edge technology ... computerized peripheral vascular package available in the US ... which allows you to do vascular examinations in ... while storing patient waveforms and data in a ...
... first of an exciting new range ... Low Coherence Reflectometry) technology,our Slitlamp-mounted* Pachymeter ... 1m and this non-contact.,This allows ... any time,and without concerns about sterilization, ...
... provides optimum head hyperextension, open airway, and a ... Placed at strategic locations throughout the hospital, the ... started immediately, and easy conversion to Thumper CPR ... be done in less than 30 seconds. ,Slide ...
Designed for Glaucoma & LASIK Screening....
Medicine Products: